Live Clinical Trial updates

Live Clinical Trial news coverage of developments with the latest updates. Stay on top of latest Clinical Trial news stories and find out what just happened, what is going on with Clinical Trial. The latest real-time news updates and headlines on Clinical Trial
Few Older Americans Seek Counseling: Potential Benefits
Parasite Diagnosis Key for Dog, Human Health
IU Appoints Global Orthopedic Exec as CEO of NSF IMPACT
Expanding Access To Pediatric Dental Care
AI Model Powers Precision Lp
Landmark Study Redefines Rare Disorders
Employers Seek Resilient Staff, Risk Burnout
Blood Biomarker Tracks Lecanemab Response in Alzheimer's
Aortic Structure Tied to Midlife Pulse Pressure Rise
Research Probes Epilepsy Drug Safety With Anticoagulants
UWA Tall Poppies Scoop New National Awards
K-Beauty Hits Coles: Supermarket Skincare Glows Up
Magnetic Pulses Reprogram Immune Cells to Combat Cancer
Enhertu Shows 14.3-Month PFS in HER2+ Lung Cancer Trial
Tagrisso Achieves 8-Year Survival in EGFR Lung Cancer
Planning Boost Frees 1500 Bed Nights in Hawke's Bay
Victoria Codifies Belief as Cornerstone of Care
WAs First Childrens Hospice Completed
Zidesamtinib Shows 93% Response in ROS1-positive NSCLC
Eight-Year ADAURA Update: Osimertinib Boosts Survival
Trastuzumab Deruxtecan Boosts Survival in HER2 Lung Cancer
Dr Tass Warns Peptide Enthusiasm Has Outpaced Evidence
Fatigue Often Missed as Liver Disease Signal
KAIST, KIOM Unveil Wearable Microneedle For Pain Relief
Costly Phosphate? Homegrown Fertilizer Solution
$14M Partnership to Enhance Drought Resilience in Australia
Research Finds Low Overdiagnosis In Breast Cancer Screening
Clover Boost: Fortune for Dairy Farmers?
Specialist Fee Crackdown Must Target More Than Outliers
UQ Research: Creativity and Impact Highlighted
Specialist Doctor Fee Crackdown Must Go Beyond Extreme Outliers
Hidden Rhythms Drive Heart Rate Dynamics
PBS Adds First Biologic for Uncontrolled COPD
KAIST, KIOM Create Wearable Pain-Relief Device
MAVERICK Trial Backs Brain MRI Alone for Lung Cancer
Phase III TAISHAN-302: Tam-Peli Boosts Survival in SCLC
ARTEMIS-008: Risvutatug Boosts Survival in Lung Cancer
Ivonescimab Boosts Survival in PD-L1+ Advanced NSCLC
Sacituzumab, Pembrolizumab Combo Misses NSCLC Targets
Birthing Services Returning To Cooktown And Biloela
Pumitamig Plus Elfetabart Shows Promise in Lung Cancer
Tarlatamab Dosing Shows Promise in Small Cell Lung Cancer
Therapy Fails to Boost Survival After Dual Immunotherapy
Phase 1 Backs Phase 3 Dose for Lung Cancer Drug
Atezolizumab Combo Doubles Event-Free Survival in NSCLC
Subcutaneous Tarlatamab Safe, Effective in SCLC Trial
SERENA-4 Trial: Etcamah, Palbociclib in ER+ Breast Cancer
UNC Unveils Tool to Identify High-Risk Cancer Periods